Apotea AB (publ)

Apotea AB (publ) EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apotea AB (publ) (APOTEA.ST) as of Nov 4, 2026 is 466.00 M SEK. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 392.40 M SEK — a change of 18.76% (higher).

EBITDA

466.00 MSEK

YoY

18.76%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apotea AB (publ) is 2025 466.00 M SEK. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apotea AB (publ) was 2024 392.40 M SEK. It decreases by 18.76% higher compared to the previous year.

The Apotea AB (publ) EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
183.37 M SEK
Jan 1, 2022
119.00 M SEK
Jan 1, 2023
225.40 M SEK
Jan 1, 2024
392.40 M SEK
Jan 1, 2025
466.00 M SEK
The Apotea AB (publ) EBITDA history
YEAREBITDAYoY
466.00 MSEK+18.76%
392.40 MSEK+74.09%
225.40 MSEK+89.41%
119.00 MSEK-35.10%
183.37 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Apotea AB (publ) Stock analysis

What does Apotea AB (publ) do? Apotea AB (publ) is a publicly listed company based in Stockholm, Sweden, operating within the Consumer Staples sector, specifically in the Retail industry. The company provides an online pharmacy service offering both non-prescription and prescription medications, alongside wholesale trade of cosmetics, general drugs, and other pharmacy-related products. Apotea AB (publ) has a workforce of 725 full-time employees. The company completed its initial public offering (IPO) on December 6, 2024, and is listed on the Stockholm Stock Exchange under the ticker symbol APOTEA.ST. Its official website is www.apotea.se. Apotea AB (publ) operates through a combination of online platforms and physical retail locations, delivering pharmacy services directly to consumers. The company's business model integrates digital commerce with traditional retail, focusing on accessibility and convenience for customers seeking pharmaceutical and cosmetic products. Apotea AB (publ) is headquartered in Stockholm, Sweden, and serves customers primarily within the Swedish market. The company's operations are centered around providing a comprehensive range of pharmacy-related products and services, emphasizing both online and offline retail channels. Apotea AB (publ) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apotea AB (publ) stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apotea AB (publ) is 466.00 M SEK in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apotea AB (publ) changed from 392.40 M SEK to 466.00 M SEK, representing a 18.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Apotea AB (publ) since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Apotea AB (publ) historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Apotea AB (publ)

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Apotea AB (publ)